Literature DB >> 8958989

Biochemistry and molecular regulation of matrix macromolecules in abdominal aortic aneurysms.

A Ghorpade1, B T Baxter.   

Abstract

Past concepts of aneurysmal dilatation as a passive process of attenuation are oversimplified and inaccurate. Aneurysm formation is a complex remodeling process that involves both synthesis and degradation of matrix proteins. Interstitial procollagen gene expression is increased in AAA compared to AOD or normal aorta, whereas tropoelastin gene expression is decreased in both AOD and AAA. The medial elastin network is disrupted and discontinuous in small AAA. Thus, the growth rate of an established AAA may well relate to the balance between collagen synthesis and degradation. Although the increased procollagen expression found in AAA may represent a compensatory response, understanding the factors that modulate matrix metabolism in AAA may allow for development of pharmacologic strategies which effectively inhibit the growth of small aneurysms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958989     DOI: 10.1111/j.1749-6632.1996.tb33305.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

Review 1.  Integrins and extracellular matrix in mechanotransduction.

Authors:  Martin Alexander Schwartz
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-11-17       Impact factor: 10.005

2.  Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation.

Authors:  Jie Zhang; Jiusong Sun; Jes S Lindholt; Galina K Sukhova; Mark Sinnamon; Richard L Stevens; Roberto Adachi; Peter Libby; Robert W Thompson; Guo-Ping Shi
Journal:  Circ Res       Date:  2011-04-14       Impact factor: 17.367

3.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms.

Authors:  G P Shi; G K Sukhova; A Grubb; A Ducharme; L H Rhode; R T Lee; P M Ridker; P Libby; H A Chapman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

4.  Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution.

Authors:  Ziad Touat; Veronique Ollivier; Jianping Dai; Marie-Genevieve Huisse; Annie Bezeaud; Uriel Sebbag; Tony Palombi; Patrick Rossignol; Olivier Meilhac; Marie-Claude Guillin; Jean-Baptiste Michel
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

Review 5.  Molecular targets in aortic aneurysm for establishing novel management paradigms.

Authors:  Chengkai Hu; Kai Zhu; Jun Li; Chunsheng Wang; Lao Lai
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

6.  Recent advances in the application of computational mechanics to the diagnosis and treatment of cardiovascular disease.

Authors:  Juan C Del Alamo; Alison L Marsden; Juan C Lasheras
Journal:  Rev Esp Cardiol       Date:  2009-07       Impact factor: 4.753

7.  Smoking status and common carotid artery intima-medial thickness among middle-aged men and women based on ultrasound measurement: a cohort study.

Authors:  Amy Z Fan; Maura Paul-Labrador; C Noel Bairey Merz; Carlos Iribarren; James H Dwyer
Journal:  BMC Cardiovasc Disord       Date:  2006-10-26       Impact factor: 2.298

8.  Inflammatory cells in the ascending aortic aneurysm in patients with type 2 diabetes versus patients with hypertension.

Authors:  Aleksandra Milutinović; Ruda Zorc-Pleskovič
Journal:  Bosn J Basic Med Sci       Date:  2022-04-01       Impact factor: 3.363

9.  Factors affecting the postoperative mortality in the ruptured abdominal aortic aneurysm.

Authors:  Hyo Yeong Ahn; Sung Woon Chung; Chung Won Lee; Min Su Kim; Sangpil Kim; Chang Won Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-08-03

10.  Preliminary analysis of proteome alterations in non-aneurysmal, internal mammary artery tissue from patients with abdominal aortic aneurysms.

Authors:  Christina Lund Kidholm; Hans Christian Beck; Julie Bukh Madsen; Nikolai Bjødstrup Palstrøm; Jes Sanddal Lindholt; Lars Melholt Rasmussen
Journal:  PLoS One       Date:  2018-02-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.